Expanded Access Program for MK-3475

Posted By
5/12/2014 11:03am
View other posts by
Activity
Replies: 2

Anyone know if any hospital starting the Expanded Access Program ( EPA ) for MK-3473 (Lambrolizumab/Pembrolizumab) is allowing melanoma patients to participate in the  EPA without having taken Ipilimumab first?

The EAP is only available to those patients who have progressed on Ipi (Yervoy) or if they are BRAF positive, a BRAF and/or MEK therapy.

All things are possible through God!

Rosa is correct.  Break down of EAP if you are interested:  http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2014/03/expanded-access-program-for-mercks-anti.html

Wishing you my best.  Celeste

chaoticallypreciselifeloveandmelanoma.blogspot.com